Pharmaceuticals & Healthcare
Kazakhstan’s pharmaceuticals and healthcare sector is undergoing significant regulatory modernisation, with the government prioritising domestic production capacity, import substitution, and alignment with international pharmaceutical standards. Foreign pharmaceutical companies entering the Kazakhstani market face a structured registration and licensing regime administered by the Ministry of Health and the Committee for Medical and Pharmaceutical Control.
Bond Stone advises international pharmaceutical companies, medical device manufacturers, and healthcare investors on market entry strategy, regulatory compliance, distribution agreement structuring, and corporate establishment. Our firm has advised Turkish pharmaceutical clients on regulatory due diligence and commercial agreement structuring for the Kazakhstani market, including engagement with the mandatory drug registration and pricing framework.
The legal framework governing pharmaceuticals in Kazakhstan requires careful attention to product registration timelines, pricing regulation for medicines included on the guaranteed benefit package, and local partnership requirements for certain distribution activities. Healthcare facility licensing and medical tourism investment present additional structuring considerations for foreign investors.
Our Pharmaceuticals & Healthcare practice covers: pharmaceutical market entry advisory; drug registration and regulatory compliance; distribution and agency agreement structuring; healthcare facility licensing; medical device registration; corporate establishment for pharmaceutical operations; employment law compliance for clinical staff; and commercial dispute resolution.
